Диссертация (Сравнительный анализ клинического течения и микробного пейзажа у больных с различными формами рожи), страница 27

–P.4996–5001. ]283. Rennie R.P., Jones R.N., Mutnick A.H. Occurrence and antimicrobial susceptibilitypatterns of pathogens isolated from skin and soft tissue infections: report from the SENTRYAntimicrobial Surveillance Program (United States and Canada, 2000) //Diagn Microbiol InfectDis. -2003. –V. 45. –P.287–293.284. Rennie R.P., Jones R. N., Mutnick A. H. SENTRY Program Study Group (NorthAmerica). Occurrence and antimicrobial susceptibility patterns of pathogenesis isolated fromskin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program(United States and Canada, 2000) //Diagn Microbiol Infect Dis.

-2003. -Vol.45 (4). -р.287-293.285. Rohrer S., Bischoff M., Rossi J., Berger-Bächi B. Mechanisms of methicillin resistance.In: A.C. Fluit and F.-J. Schmitz, Editors (2003). MRSA135286. Sachse S., et al. Superantigen-like gene(s) in human pathogenic Streptococcusdysgalactiae,subsp equisimilis: genomic localisation of the gene encoding streptococcalpyrogenic exotoxin G [speG(dys)] //FEMS Immunol Med Microbiol .

-2002. –V.34. –P.159–167.287. Sande L., Flores A.R. Feigin and Cherry’s Textbook of Pediatric Infectious Diseases.Saunders, an imprint of Elsevier Inc. -2014. –P.1140-1152.288. Saouda M., Wu W., Conran P., Boyle M.D. Streptococcal pyrogenic exotoxin Benhances tissue damage initiated by other Streptococcus pyogenes products //J. Infect. Dis. 2001. -Vol.184. -N.6. -P.723-731.289. Saxena S., Thompson P., Birger R.et al.

M. Increasing skin infections andStaphylococcus aureus complications in children, England, 1997–2006. //Emerg Infect Dis. 2010. –V.16. –P.530–533.290. Schalén C., Truedsson L., Christensen K.K., Christensen P. Blocking of antibodycomplement-dependent effector functions by streptococcal IgG Fc-receptor and staphylococcalprotein A. //Acta Pathol Microbiol Immunol Scand B. -1985.-V. 93(6). –P.395-400.291.

Schrager H.M., Alberti S., Cywes C. et al. Hyaluronic acid capsule modulates Mprotein-mediated adherence and acts as a ligand for attachment of group A Streptococcus toCD44 on human keratinocytes //J. Clin. Invest. -1998. -Vol.101. -N.8. -Р.1708-1716.292. Schrock J.W., Laskey S., Cydulka R.K. Predicting observation unit treatment failuresin patients with skin and soft tissue infections.// Int J Emerg Med. -2008. –V. 1(2). –P.85-90.293. Schweiger S.E., Weinberg J.M. Novel antibacterial agents for skin and skin strutureinfections.// J Am Acad Dermatol. -2004. –V.50. –P.331-340.294.

Semel J.D.,Goldin H. Asociation of athlete’s foot with cellulitis of the lowerextremities: diagnostic value of bacterial cultures of ipsilateral space samples //Clin Infect Dis 1996. -23. -P.1162-1164.295. Shallcross LJ, Fragaszy E, Johnson AM, et al. The role of the Panton-Valentineleucocidin toxin in staphylococcal disease: a systematic review andmeta-analysis. //Lancet InfectDis -2012;-V.13(1) -P.43–54.296. Shimomura Yumi, Kayo Okumura, Somay Yamagata Murayama,et al. Completegenome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp.equisimilis strain causing streptococcal toxic shock syndrome (STSS)/ /BMC Genomics -2011.

–V.12. –P.17297. Shorr A.F. Epidemiology and economic impact of meticillin-resistant Staphylococcusaureus: review and analysis of the literature. //Pharmaco Economics. -2007. –V.25. –P.751–768.136298. Simonsen S.M., van Orman E.R., Hatch B.E. et al. Cellulitis incidence in a definedpopulation. //Epidemiol Infect. -2006. –V. 134. –P.293–299299. Sletvold H., Johnsen P.J., Wikmark O.G.,et al. Tn1546 is part of a larger plasmidencoded genetic unit horizontally disseminated among clonal Enterococcus faecium lineages. //J.Antimicrob.

Chemother. -2010. –V.65 -P.894–1906.300. Steinz K., Schubert S., Harder J., Gerdes S., Mrowietz U., Gläser R. Bacterial softtissue infection in psoriasis despite induction of epidermal antimicrobial peptides. //Exp.Dermatol. -2014. –V. 23(11). –P. 862-864.301. Stevens D.L. Cellulitis and erysipelas/in Netter’s Infectious Diseases Elaine C. Jongand Dennis L.

Stevens, Saunders, an imprint of Elsevier 2012; 81-86.302. Sylvetsky N., Raveh D., Schlesinger Y. et al. Bacteremia due to beta-hemolyticStreptococcus group G: increasing incidence and clinical characteristics of patients // Am J Med-2002 –V.112. -P.622–626303. Sun H.L., Wang H., Chen M.J. et al. An antimicrobial resistance surveillance of grampositive cocci isolated from 12 teaching hospitals in China in 2009.[Article in Chinese]//Zhonghua Nei Ke Za Zhi. -2010. –V. 49(9).

P.735-40.304. Sohn A., Garrett D., Sinkowitz-Cochran R. . Prevalence of nosocomial infections inneonatal intensive care unit patients: results from the first national point-prevalence survey.// J.Pediatr. -2001. –V.136. -P.821- 827.305. Stefani S., Varaldo P. Epidemiology of methicillin-resistant staphy-lococci in Europe.//Clin. Microbiol. Infect. -2004. –V.9 (12) -P.1179-1186306. Takahashi T., Ubukata K., Watanabe H. Invasive infection caused by Streptococcusdysgalactiae subsp.

equisimilis: characteristics of strains and clinical features //J InfectChemother -2011. –V. 17. –P.1–10307. Tan L.K., Eccersley L.R., Sriskandan S. Current views of haemolytic streptococcal pathogenesis//Curr Opin Infect Dis. -2014. -V.27(2). -P.155-64.308. Tay E.Y., Fook-Chong S., Oh C.C., Thirumoorthy T., Pang S.M., Lee H.Y. CellulitisRecurrence Score: a tool for predicting recurrence of lower limb cellulitis. //J Am AcadDermatol. -2015.-V. 72(1).

–P. 140-145.309. Taylor A.R. Methicillin-resistant Staphylococcus aureus infections. //Prim Care -2013.–V.40(3). -P.637–654.310. Thormsberry C. . The development of antimicrobial resistance in Staphylococcus. //J.Antimicrob. Chem. -1998. –V. 21(suppl). –P. 9-16137311.

Trenchs V., Hernandez-Bou S, Bianchi C. et al. Blood Cultures are not Useful in theEvaluation of Children with Uncomplicated Superficial Skin and Soft Tissue Infections //PediatrInfect Dis J. -2015.312. Tsai C.T., Chi C.Y., Ho C.M.

et al. Correlation of virulence genes to clinicalmanifestations and outcome in patients with Streptococcus dysgalactiae subspecies equisimilisbacteremia.// J Microbiol Immunol Infect. -2013. pii: S1684-1182(13)00164-3313. Vandamme P., Pot B., Falsen E.et al. ( Taxonomic study of lancefield streptococcalgroups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp.equisimilis subsp. nov. //Int J Syst Bacteriol -1996.

–V.46. –P.774–781314. VarellaCoelho M.L, SantosNascimento J.D etal.. Activityofstaphy-lococcalbacteriocins against Staphylococcus aureus and Streptococcus agalac-tiae involved in bovinemastitis. //Res. Microbiol. -2007. –V.158. –P.625–630.315.Varma P., Nisha N., Dinesh K.R. et al. Anti-infective properties of Lactobacillusfermentum against Staphylococcus aureus and Pseudomonas aeruginosa. //J. Mol. Microbiol.Biotechnol. -2011. –V. 20. –P.137–143.316. Veyssier-Belot C., Lejoyeux-Chartier F., Bouvet A.

et al. Erysipelas, cellulitis and othersevere Streptococcus pyogenes skin infections // Presse Med. -1999. -Vol. 28. -№35. -P.19591965.317. Vinh DC, Embil JM. Rapidly progressive soft tissue infections. //Lancet InfectDis. 2005.

-V. 5. -P.501–513.318. Volz K.A., Canham L., Kaplan E., et al.. Identifying patients with cellulitis who arelikely to require inpatient admission after a stay in an ED observation unit //Am J Emerg Med. 2013. -31(2). -P.360-364.319. Wang Hy, Kim S., Kim J. et al. Multiplex real-time pcr assay for rapid detection ofmethicillin-resistant staphylococci directly from positive blood cultures. ).

//J Clin Microbiol. 2014. –V. 52(6) -P.1911-20.320. Watanabe S., Kirikae T., Miyoshi-Akiyama T. Complete genome sequence ofStreptococcus dysgalactiae subsp. equisimilis 167 carrying Lancefield group C antigen andcomparative genomics of S. dysgalactiae subsp. equisimilis strains. //Genome Biol Evol.

-2013.–V. 5. –P.1644–1651321. Wessels M.R.. Chapter 130. Streptococcal and Enterococcal Infections// in Harrison’sPrinciples of Internal Medicine, 17th Edition (Harrison’s Online) The McGraw-Hill Companies,Inc., 2008, http://www.accessmedicine.com/.322. Wolf B. B., Gibson C. A., Kapur V. et al. Proteolytically active streptococcal pyrogenicexotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the138receptor from the cell surface //J. Biol. Chem. -1994. -Vol.269. -P.30682-30687323. Wong C.H., Chang H.C., Pasupathy S., et al. Necrotizing fasciitis: clinical presentation,microbiology,and determinants of mortality.

//J Bone Joint Surg Am. -2003. -85-A(8). -P.1454-60.324. Wong CJ, Stevens DL. Serious group A streptococcal infections. //Med Clin North Am-2013. –V.97(4). -P.721–736325. Woo P.C.Y., Fung A.M.Y., Lau S.K.P. et al. Group G Beta-Hemolytic StreptococcalBacteremia Characterized by 16S Ribosomal RNA Gene Sequencing // J. Clin. Mirob.- 2001. Vol. 39. - No.

9 , -P. 3147–3155 .326. Wylie F.P., Kaplan S.L., Mason E.O., Allen C.H.. Needle aspiration for the etiologicdiagnosis of children with cellulitis in the era of community-acquired methicillin-resistantStaphylococcus aureus //Clin Pediatr (Phila) -2011. –V.50(). –P.503-507327. Zhao J., Hayashi T., Saarinen S. et al. Cloning, expression, and characterization of thesuperantigen streptococcal pyrogenic exotoxin G from Streptococcus dysgalactiae //InfectImmun -2007.

–V. 75. –P.1721–1729328. Zilberberg M.D., Shorr A.F., Micek S.T.et al. Epidemiology and out-comes ofhospitalizations with complicated skin and skin-structure infections: implications of healthcareassociated infection risk factors.// Infect Control Hosp Epidemiol. -2009. –V.30. -P.1203–1210..